Literature DB >> 17906983

The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models.

Slavka Lukacova1, Brita S Sørensen, Jan Alsner, Jens Overgaard, Michael R Horsman.   

Abstract

AIM: To investigate the direct relationship between tumour hypoxia and lactate dehydrogenase (Ldh) levels in serum and tumour in two different pre-clinical murine models.
MATERIALS AND METHODS: Experiments were performed in CDF1 or C3H/ Km mice implanted with a C3H mammary carcinoma and SCCVII squamous cell carcinoma, respectively. Low oxygen breathing for 1-72 h was used to increase tumour hypoxia. Ldh activity was measured in the serum and tumour cytosole with a colorimetric method. Tumour Ldha mRNA levels were assessed with RT-PCR. RESULTS; The serum Ldh in non-tumour bearing CDF1 mice and C3H/km mice was 10.592 U/ml and 1292 U/ml, respectively. For C3H mammary carcinoma bearing mice, a positive correlation between tumour volume and tumour and serum Ldh was found. Tumour Ldh in SCCVII carcinomas also increased with increasing tumour volume, but no volume dependence of serum Ldh was found. Low oxygen breathing caused a 2-3 fold increase in tumour Ldha mRNA in both tumour models. In C3H mammary carcinoma bearing mice, serum and tumour Ldh significantly increased after 48 and 72 hours of hypoxia, respectively. Low oxygen breathing did not change serum and tumour Ldh in SCCVII carcinoma bearing mice. Reoxygenation for 4 or 24 hours had no additional effect on Ldh activity in any of the models. DISCUSSION: Serum Ldh activity can be a marker for tumour burden in certain types of cancer. The relationship between serum and tumour Ldh and tumour hypoxia has not been confirmed. However, Ldha mRNA may be a potential new marker of tumour hypoxia and should be further investigated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17906983     DOI: 10.1080/02841860701644086

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  9 in total

1.  Progressive tumor growth-associated altered tumor microenvironment: implications in a tumor stage-dependent modulation in survival of a murine T cell lymphoma.

Authors:  Vivek Singh; Sukh Mahendra Singh
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-06       Impact factor: 4.553

2.  Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.

Authors:  James C Yao; Alexandria T Phan; David Z Chang; Robert A Wolff; Kenneth Hess; Sanjay Gupta; Carmen Jacobs; Jeannette E Mares; Andrea N Landgraf; Asif Rashid; Funda Meric-Bernstam
Journal:  J Clin Oncol       Date:  2008-09-10       Impact factor: 44.544

3.  Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma.

Authors:  Martin Grimm; Dorothea Alexander; Adelheid Munz; Juergen Hoffmann; Siegmar Reinert
Journal:  Clin Exp Metastasis       Date:  2012-11-25       Impact factor: 5.150

4.  Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area.

Authors:  Zhengbo Wei; Xianjie Zeng; Jian Xu; Xuwei Duan; Ying Xie
Journal:  Onco Targets Ther       Date:  2014-05-15       Impact factor: 4.147

5.  Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patients.

Authors:  Mau-Shin Chi; Cheng-Yen Lee; Su-Chen Huang; Kai-Lin Yang; Hui-Ling Ko; Yen-Kung Chen; Chen-Han Chung; Kuang-Wen Liao; Kwan-Hwa Chi
Journal:  Oncotarget       Date:  2015-10-06

6.  First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma.

Authors:  Maxine Tran; Arash Latifoltojar; Joana B Neves; Marianthi-Vasiliki Papoutsaki; Fiona Gong; Arnaud Comment; Ana S H Costa; Matthias Glaser; My-Anh Tran-Dang; Soha El Sheikh; Wivijin Piga; Alan Bainbridge; Anna Barnes; Tim Young; Hassan Jeraj; Ramla Awais; Sola Adeleke; Christopher Holt; James O'Callaghan; Frazer Twyman; David Atkinson; Christian Frezza; Erik Årstad; David Gadian; Mark Emberton; Shonit Punwani
Journal:  BJR Case Rep       Date:  2019-03-05

7.  Microcirculatory disturbance in acute liver injury.

Authors:  Akifumi Kuwano; Miho Kurokawa; Motoyuki Kohjima; Koji Imoto; Shigeki Tashiro; Hideo Suzuki; Masatake Tanaka; Seiji Okada; Masaki Kato; Yoshihiro Ogawa
Journal:  Exp Ther Med       Date:  2021-04-09       Impact factor: 2.447

8.  The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.

Authors:  Long Bai; Ze-Yu Lin; Yun-Xin Lu; Qin Chen; Han Zhou; Qi Meng; Chun-Ping Lin; Wan-Lan Huang; Yun-Le Wan; Zhi-Zhong Pan; De-Shen Wang
Journal:  Cancer Med       Date:  2021-10-12       Impact factor: 4.452

9.  Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection.

Authors:  Long Bai; Xiao-Luan Yan; Yun-Xin Lu; Qi Meng; Yu-Ming Rong; Liu-Fang Ye; Zhi-Zhong Pan; Bao-Cai Xing; De-Shen Wang
Journal:  Ann Surg Oncol       Date:  2022-01-04       Impact factor: 4.339

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.